Search all

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Australia

Austria

Belgium

Brazil *

Canada

China *

Denmark

Finland

France

Germany

Hong Kong *

India *

Ireland

Italy

Japan *

Luxembourg

Mexico *

Netherlands

Norway

Philippines *

Republic of Korea *

Singapore *

Spain

Sweden

Switzerland

Thailand *

United Kingdom

United States

IVISense MMP 645 FAST Fluorescent Probe (MMPSense)

Name: IVISense MMP 645 FAST Fluorescent Probe (MMPSense)
Price: 706.6 USD
Availability: InStock

Matrix metalloproteinases (MMPs) are calcium-dependent zinc containing endopeptidases responsible for the degradation of most of extracellular matrix proteins during organogenesis, growth and normal tissue turnover. MMPs play a role in almost every biological cell process from embryo implantation to cell death and have been implicated in a wide range of diseases including inflammation, arthritis, pulmonary disease, cancer and more.

Revvity’s IVISense™ MMP NIR activatable fluorescence probes (MMPSense®) are designed to evaluate many disease related processes including cancer progression, rheumatoid arthritis, pulmonary disease and more as well as evaluating therapeutic efficacy of potential drug candidates.

View product information

Feature	Specification
Unit Size	1 vial (10 doses)
Specificity	Matrix Metalloprotease

Request more information

View product information

Product variants

Wave Length: 645 nm

Part #:

NEV10100

List price

USD 706.60

Your online price:

Wave Length: 680 nm

Part #:

NEV10126

List price

USD 702.04

Your online price:

Wave Length: 750 nm

Part #:

NEV10168

List price

USD 702.04

Your online price:

For research use only. Not for use in diagnostic procedures.

Total list price:

USD 706.60

Product information

Overview

IVISense MMP 645 FAST is excited by 649 nm excitation light, and emits at 666 nm. MMP 645 FAST is a member of a family of activatable fluorescent imaging agents comprising a novel architecture termed F.A.S.T. (Fluorescent Activatable Sensor Technology), that allows for an earlier optimal imaging window of 6-24 hours after injection, facilitating detection of early MMP activity changes, for example in acute models of inflammation or stroke. Including IVISense MMP 645 FAST in careful experimental design allows for multiplexing with other channels and/or imaging times, and so can be paired with other probes to achieve maximum efficiency and flexibility in imaging.

Specifications

Other specifications

Brand	IVISense
Fluorescent Agent Type	Enzyme activated
Imaging Modality	Fluorescence
Shipping Conditions	Shipped in Blue Ice
Specificity	Matrix Metalloprotease
Storage Conditions	+2 to +8 °C
Therapeutic Area	Arthritis Atherosclerosis Cardiovascular Inflammation Oncology Pulmonary Vascular
Unit Size	1 vial (10 doses)
Wave Length	645 nm